Locations
New York, USA · Los Angeles, CA, USA · New York, NY, USA · Canal Street, New York, NY, USA · Union Square, New York, NY, USA
Size
11 - 50 employees
Stage
Seed
founded in
2021
Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick-and-mortar clinics with an easy-to-implement continuous care platform that saves time, increases revenue, and improves patient outcomes. The company has announced agreements with 771 GI providers, representing 15% of all independent GI providers in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: IBS and IBD (over 40 million affected), GERD and Celiac (over 50 million affected), MASH/MASLD, what was previously called “fatty liver disease” (over 80 million), and Obesity (over 100 million). The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2 million EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization).
Something looks off?On-site & Remote
